AMPEL BioSolutions Employee Directory
Biotechnology ResearchVirginia, United States11-50 Employees
AMPEL BioSolutions is a Charlottesville, Virginia–based biotechnology company focused on advancing precision medicine for novel therapies. The firm combines data analysis with clinical science to identify and validate drug targets, supporting the development of targeted treatments and enabling decisions that aim to match therapies to patients at the right time. Serving researchers and clinical development teams, AMPEL addresses challenges in drug discovery and development by providing analytical and translational capabilities that inform target priority, risk assessment, and potential therapeutic impact. Founded and led by a team with backgrounds across basic and clinical research, medicine, and risk management, the company emphasizes a broad, global understanding of the biomedical landscape to tackle complex research questions. In recent years, AMPEL has announced developments such as a genomic precision medicine test lineup and blood-based assays for cardiovascular and kidney disease contexts, reflecting its emphasis on integrating genomic data with clinical insights to support precision medicine initiatives.